These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1726208)

  • 61. [Clinical evaluation of cefpodoxime proxetil, a new oral cephem, in the treatment of respiratory tract infections with the special reference to community-acquired Streptococcus Pneumoniae infections].
    Akiyama O; Ito T; Ogata M; Okano H; Kabe J; Kawakami M; Kida K; Kudo K; Komatsuzaki K; Konno K
    Jpn J Antibiot; 1995 Apr; 48(4):522-8. PubMed ID: 7783315
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Microbiological evaluation of cefpodoxime proxetil.
    Wiedemann B; Luhmer E; Zühlsdorf MT
    Drugs; 1991; 42 Suppl 3():6-12. PubMed ID: 1726210
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Azithromycin, erythromycin and cloxacillin in the treatment of infections of skin and associated soft tissues. European Azithromycin Study Group.
    Daniel R
    J Int Med Res; 1991; 19(6):433-45. PubMed ID: 1663466
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of once daily cefpodoxime proxetil suspension and thrice daily cefaclor suspension in the treatment of acute otitis media in children.
    Tsai HY; Huang LM; Chiu HH; Hsueh PR; Lee PI; Lu CY; Chiu TF; Lin HC; Lee CY
    J Microbiol Immunol Infect; 1998 Sep; 31(3):165-70. PubMed ID: 10496153
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Clinical studies on cefpodoxime proxetil in the pediatric fields].
    Watanabe A; Koshinami M
    Jpn J Antibiot; 1989 Jul; 42(7):1471-6. PubMed ID: 2810723
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharyngitis/tonsillitis: European and United States experience with cefpodoxime proxetil.
    Dajani AS
    Pediatr Infect Dis J; 1995 Apr; 14(4 Suppl):S7-11. PubMed ID: 7792129
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Reevaluation of current antimicrobials. Cefpodoxime proxetil. Discussion].
    Jpn J Antibiot; 1995 Feb; 48(2):183-90. PubMed ID: 7745807
    [No Abstract]   [Full Text] [Related]  

  • 68. Twice daily cefpodoxime proxetil compared with thrice daily amoxicillin/clavulanic acid for treatment of acute otitis media in children.
    Gehanno P; Barry B; Bobin S; Safran C
    Scand J Infect Dis; 1994; 26(5):577-84. PubMed ID: 7855555
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacokinetic study and clinical evaluation of cefpodoxime proxetil in the elderly with impaired renal function.
    Ishioka T
    J Chemother; 1995 Nov; 7 Suppl 4():122-3. PubMed ID: 8904130
    [No Abstract]   [Full Text] [Related]  

  • 70. The comparative plasma pharmacokinetics of intravenous cefpodoxime sodium and oral cefpodoxime proxetil in beagle dogs.
    Brown SA; Boucher JF; Hubbard VL; Prough MJ; Flook TF
    J Vet Pharmacol Ther; 2007 Aug; 30(4):320-6. PubMed ID: 17610405
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Concentrations of cefpodoxime in plasma, adenoid, and tonsillar tissue after repeated administrations of cefpodoxime proxetil in children.
    Bairamis TN; Nikolopoulos TP; Kafetzis DA; Begue P; Lenfant B; Kandiloros DC; Apostolopoulos NJ
    J Antimicrob Chemother; 1996 Apr; 37(4):821-4. PubMed ID: 8722549
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of timing of food on absorption of cefpodoxime proxetil.
    Borin MT; Driver MR; Forbes KK
    J Clin Pharmacol; 1995 May; 35(5):505-9. PubMed ID: 7657851
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cefpodoxime proxetil--a new oral cephalosporin.
    Med Lett Drugs Ther; 1992 Nov; 34(884):107-8. PubMed ID: 1435506
    [No Abstract]   [Full Text] [Related]  

  • 74. Concentrations of cefpodoxime in plasma and lung tissue after a single oral dose of cefpodoxime proxetil.
    Couraud L; Andrews JM; Lecoeur H; Sultan E; Lenfant B
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():35-40. PubMed ID: 2292528
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Study of the bactericidal effect of cefpodoxime using an in vitro pharmacokinetic model].
    Caisson A; Chantot JF
    Pathol Biol (Paris); 1991 Oct; 39(8):774-9. PubMed ID: 1762835
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In vitro antimicrobial activities of lactoferrin, its concomitant use with cefpodoxime proxetil and clinical effect of cefpodoxime proxetil.
    Chimura T; Hirayama T; Nakahara M
    Jpn J Antibiot; 1993 Jun; 46(6):482-5. PubMed ID: 8360983
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Penetration of cefpodoxime proxetil in lung parenchyma and epithelial lining fluid of noninfected patients.
    Muller-Serieys C; Bancal C; Dombret MC; Soler P; Murciano G; Aubier M; Bergogne-Berezin E
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2099-103. PubMed ID: 1444291
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Bacteriological, pharmacokinetic and clinical studies on cefpodoxime proxetil in the pediatric field].
    Kimura H; Takeuchi H; Ishikawa H; Hayakawa F; Yamamoto N; Nakao Y; Kuno K
    Jpn J Antibiot; 1989 Jul; 42(7):1593-606. PubMed ID: 2562789
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [A clinical study on cefpodoxime proxetil dry syrup in pediatric infections].
    Wagatsuma Y; Takase A; Fukushima N; Ishikawa A; Takahashi S
    Jpn J Antibiot; 1989 Jul; 42(7):1464-70. PubMed ID: 2810722
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Clinical and pharmacokinetic evaluation of cefpodoxime proxetil in children].
    Sakata H; Kakehashi H; Fujita K; Yoshioka H; Iseki K; Murono K; Takahashi Y
    Jpn J Antibiot; 1989 Jul; 42(7):1456-63. PubMed ID: 2810721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.